Therefore, the purpose of this study was to evaluate patients with depression in distinct MDD stages (de novo patients and patients with treatment-resistant depression), by the serum mature BDNF (mBDNF), plasma CRP, serum cortisol (SC), and the salivary CAR, aiming to compare them with those of a control group of healthy volunteers. This evidence concerns the gene BDNF and depressive disorder.